Company Overview of The Global Alliance for TB Drug Development
Key Executives for The Global Alliance for TB Drug Development
|Melvin K. Spigelman M.D.||43 Relationships||Chief Executive Officer, President and Director||67|
|Petro Terblanche||13 Relationships||President of Stakeholders Association and Director||--|
|Marshall Burke Ph.D.||No Relationships||Senior Vice President of External Affairs||--|
|Dean R. Haubrich Ph.D.||1 Relationships||Head of Project Management||--|
|Carl M. Mendel M.D., Ph.D.||No Relationships||Senior Vice President of Research and Development||61|
|View More Key Executives|
The Global Alliance for TB Drug Development Board Members*
|Name||Board Relationships||Primary Company||Age|
|Bruce L. A. Carter Ph.D.||182 Relationships||Enanta Pharmaceuticals, Inc.||73|
|Melvin K. Spigelman M.D.||43 Relationships||The Global Alliance for TB Drug Development||67|
|Petro Terblanche||13 Relationships||The Global Alliance for TB Drug Development||--|
|Mark Kessel J.D.||26 Relationships||Symphony Capital LLC||74|
|Anthony MBewu||9 Relationships||The Global Alliance for TB Drug Development||--|
The Global Alliance for TB Drug Development Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|There is no committee data available.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
INDUSTRY EXECUTIVE CHANGESThere is no Executive Change data available.
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.